ARTICLE | Clinical News
MG98: Development discontinued
December 18, 2006 8:00 AM UTC
MYG said following a strategic review of its cancer pipeline, it and partner MOGN will no longer pursue MG98 and will seek alternative development partners or arrangements for the compound. MG98 has c...